Hormone Therapy Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall Benefit
The NHLBI of the National Institutes of Health has stopped early a major clinical trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women due to an increased risk of invasive breast cancer.
Colorectal Cancer Risk Higher In People With Insulin-Requiring Type 2 Diabetes
Study concludes that patients with type 2 diabetes mellitus who require long-term insulin therapy are at a significantly increased risk for colorectal cancer.
Blocking Sugar Intake May Reduce Cancer Risk or Progression in Diabetics
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers.
Hospitalization Risks for Patients with Diabetes and Solid-Organ Malignancy
Study determines that diabetes, coexisting with solid-organ malignancies, is associated with risk of hospitalization and multiple hospitalizations. Future Science Group (FSG) announced the publication...
Diabetes Drug Shows Promise in Reducing Risk of Cancer
An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study.
Common Diabetes Drug May Help Prevent Liver Cancer
A drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research.
Organic and Sustainable Foods Linked to Reduced Risk of Some Cancers and Heart Disease
Organically or sustainably grown berries and corn contain up to 58 percent more polyphenolics, natural antioxidants that are a natural defense for plants and may be good for our health.
Study: Saw Palmetto No Better Than Placebo For Enlarged Prostate
Saw palmetto, an herbal extract commonly taken to improve urinary symptoms in men with enlargement of the prostate gland, is no more effective than a placebo.
Want Better Diabetes Care? Find a Family Health Team, Says Study
According to a study published in Canadian Medical Association Journal, a shift to family health teams results in improved diabetes care. It also helps...
Study: Diabetes and Cancer; Protein Frequently Mutated in Cancer Has a Surprising Alter-Ego
A study published by Nature has defined the function of p110 alpha, the flag-ship molecule of the eight member PI3K family, which is one of the most frequently activated pathways in cancer.
Study: Low-Protein, Low-Calorie Dieters Have Reduced Levels of Hormone Linked to Cancer
Preliminary findings suggest that eating less protein may help protect against certain cancers that are not directly associated with obesity.
Mayo Clinic Researchers Report Diabetic Women Less Likely to Undergo Mammograms
Mayo Clinic researchers have found that women with diabetes were significantly less likely to undergo screening for breast cancer by mammography than patients in a control group.
Study: Antioxidant Supplementation Not Associated With Decreased Risk of Prostate Cancer
Intakes of dietary or supplemental antioxidants were not associated with a decreased risk of prostate cancer among men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Diabetes Increases Risk of Developing and Dying from Breast and Colon Cancer
Researchers have found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
Cancer Drug Use Leads to Diabetes
A drug widely used by cancer and transplant patients also comes with a downside: it leads to diabetes in as many as 15 percent of the people who take it.
Splenda Brand Rebukes New Safety Allegation About Sucralose
Heartland Food Products Group, makers of Splenda Sweeteners, is claiming that the recent CSPI rating on Sucralose is misleading to consumers. In response to the...
